Current Environment: Production

Jacklyn Omorodion | Medical Services

Programs & Services

Languages

  • English

Jacklyn Omorodion | Education

Undergraduate School

McMaster University

2014, Hamilton, Ontario, Canada

Medical School

George Washington University School of Medicine and Health Sciences

2019, Washington, DC

Residency

Pediatrics

Boston Combined Residency Program (BCRP)

2023, Boston, MA

Fellowship

Medical Genetics

Harvard Medical School Genetics Training Program

2023, Boston, MA

Jacklyn Omorodion | Certifications

  • American Board of Medical Genetics and Genomics (Clinical Genetics)

Jacklyn Omorodion | Publications

  1. Nonadherence to guidelines for genetic testing in families with ovarian cancer shows racial bias. Genet Med. 2025 Apr 19; 27(7):101444. View Nonadherence to guidelines for genetic testing in families with ovarian cancer shows racial bias. Abstract

  2. Preferences of parents from diverse backgrounds on genomic screening of apparently healthy newborns. J Genet Couns. 2025 Apr; 34(2):e1994. View Preferences of parents from diverse backgrounds on genomic screening of apparently healthy newborns. Abstract

  3. Vitelline vascular remnant causing intestinal obstruction in a patient with TARP syndrome. Birth Defects Res. 2023 08 01; 115(13):1216-1221. View Vitelline vascular remnant causing intestinal obstruction in a patient with TARP syndrome. Abstract

  4. Delayed diagnosis and racial bias in children with genetic conditions. Am J Med Genet A. 2022 04; 188(4):1118-1123. View Delayed diagnosis and racial bias in children with genetic conditions. Abstract

  5. Lysinuric protein intolerance: Pearls to detect this otherwise easily missed diagnosis. Transl Sci Rare Dis. 2020 Aug 03; 5(1-2):81-86. View Lysinuric protein intolerance: Pearls to detect this otherwise easily missed diagnosis. Abstract

  6. Shortage of generic neurologic therapeutics: An escalating threat to patient care. Neurology. 2017 Dec 12; 89(24):2431-2437. View Shortage of generic neurologic therapeutics: An escalating threat to patient care. Abstract

  7. Inpatient cost analysis for treatment of myasthenia gravis. Muscle Nerve. 2017 Dec; 56(6):1114-1118. View Inpatient cost analysis for treatment of myasthenia gravis. Abstract

BESbswy